SMAD1, along with other genes involved in the BMP/Smad signaling pathway, is repressed through NF-κB signaling pathway in bone marrow-derived mesenchymal stem cells (BMMSCs) from SLE patients [48]. This evidence concerns the gene NFKB1 and systemic lupus erythematosus.